The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Hormone therapy for transgender patients
Open accessAbstract
Many transgender men and women seek hormone therapy as part of the transition process. Exogenous testosterone is used in transgender men to induce virilization and suppress feminizing characteristics. In transgender women, exogenous estrogen is used to help feminize patients, and anti-androgens are used as adjuncts to help suppress masculinizing features. Guidelines exist to help providers choose appropriate candidates for hormone therapy, and act as a framework for choosing treatment regimens and managing surveillance in these patients. Cross-sex hormone therapy has been shown to have positive physical and psychological effects on the transitioning individual and is considered a mainstay treatment for many patients. Bone and cardiovascular health are important considerations in transgender patients on long-term hormones, and care should be taken to monitor certain metabolic indices while patients are on cross-sex hormone therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Stigma, Mental Health, and Resilience in an Online Sample of the US Transgender Population
Bockting, W. O., Miner, M. H., Swinburne Romine, R. E., Hamilton, A., & Coleman, E. (2013) · American Journal of Public Health · doi:10.2105/ajph.2013.301241 · Cited by 1,540 · cited 1×
“However, in some situations when delay of therapy may lead to psychologic and cognitive trauma in a child, it may be appropriate to commence therapy earlier (34).”
BackgroundLong-Term Treatment of Transsexuals with Cross-Sex Hormones: Extensive Personal Experience
Gooren, L. J., Giltay, E. J., & Bunck, M. C. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1809 · Cited by 308 · cited 1×
“Progestins are used by some providers, but should be used with caution as there is a theoretical risk of breast cancer associated with long-term exogenous progesterone use (15).”
BackgroundTestosterone therapy for transgender men
Irwig, M. S. (2017) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(16)00036-x · Cited by 272
Interpreting Laboratory Results in Transgender Patients on Hormone Therapy
Roberts, T. K., Kraft, C. S., French, D., Ji, W., Wu, A. H. B., Tangpricha, V., & Fantz, C. R. (2014) · The American Journal of Medicine · doi:10.1016/j.amjmed.2013.10.009 · Cited by 109 · cited 1×
“(33) looked at metabolic indices in male-to-female patients on hormone therapy in order to determine appropriate reference ranges.”
BackgroundMueller, A., Zollver, H., Kronawitter, D., Oppelt, P. G., Claassen, T., Hoffmann, I., Beckmann, M. W., & Dittrich, R. (2010) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0030-1255074 · Cited by 93 · cited 1×
“Transgender women may be at higher risk for bone loss despite estrogen use (27).”
BackgroundEffects of high dose oestrogen therapy on circulating inflammatory markers
Wilson, R., Spiers, A., Ewan, J., Johnson, P., Jenkins, C., & Carr, S. (2009) · Maturitas · doi:10.1016/j.maturitas.2009.01.009 · Cited by 59 · cited 1×
“After the age of 40, transdermal formulations are recommended as they bypass first pass metabolism and seem to be associated with better metabolic profiles (14).”
Background
Cited by
Impact of Hormone Therapy on Laboratory Values in Transgender Patients
SoRelle, J. A., Jiao, R., Gao, E., Veazey, J., Frame, I., Quinn, A. M., Day, P., Pagels, P., Gimpel, N., & Patel, K. (2019) · Clinical Chemistry · doi:10.1373/clinchem.2018.292730 · Cited by 86
Rivera, S. (2022) · Journal of the American Psychoanalytic Association · doi:10.1177/00030651221104487 · Cited by 9
Urinary Tract Infection in a Transgender Male: A Primary Care Approach
Manion, A., & James, T. S. (2024) · Journal of Pediatric Health Care · doi:10.1016/j.pedhc.2024.08.002
Metadata
- Authors
- Unger, C. A.
- Venue
- Translational Andrology and Urology
- Publisher
- AME Publishing Company
- Published
- 2016-12
- Volume
- 5
- Issue
- 6
- Pages
- 877-884
- ISSN
- 2223-4683 (ISSN-L)
- 2223-4691
- OpenAlex
- W2548724077
- Cited by
- 245
- References
- 6
- FWCI
- 22.08
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Hormone therapy for transgender patients. https://app.cochat.ai/papers/10.21037/tau.2016.09.04
- The paper
- Unger, C. A. (2016). Hormone therapy for transgender patients. Translational Andrology and Urology. https://doi.org/10.21037/tau.2016.09.04
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.